logo

Clinical Trial Calendar

Announced Date
Company Name
Ticker
Event
Indication
Period
Outcome
Details
12/03/2014
CytRx Corp.
Preliminary results from phase II trial of Aldoxorubicin
Kaposi's Sarcoma
1H 2015
12/03/2014
CytRx Corp.
Preliminary results from phase II trial of Aldoxorubicin
Glioblastoma multiforme
1H 2015
12/15/2014
Vascular Biogenics Ltd.
Top line data from phase II study of VB-201
Psoriasis
Q1 2015
12/15/2014
Vascular Biogenics Ltd.
Top line data from phase II study of VB-201
Ulcerative Colitis
Q1 2015
01/06/2015
Can-Fite BioPharma Ltd.
Top line data from Phase II/III trial of CF101
Psoriasis
Q1 2015
01/06/2015
Can-Fite BioPharma Ltd.
Data from Phase II study of CF101
Glaucoma.
1H 2015
01/08/2015
CTI BioPharma Corp.
Topline data from Phase 3 trial of Pacritinib
Myelofibrosis
Late Q1 2015
12/22/2014
Nuvo Research Inc.
Top-line data from phase 2 trial of WF10
Refractory allergic rhinitis
Mid Feb 2015